Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (1)
- (-) Bioenergy (3)
- (-) Biomedical (1)
- (-) Critical Materials (2)
- (-) Machine Learning (1)
- (-) Transportation (1)
- 3-D Printing/Advanced Manufacturing (2)
- Chemical Sciences (2)
- Climate Change (1)
- Composites (1)
- Computer Science (5)
- Energy Storage (4)
- Environment (2)
- Isotopes (3)
- Materials (1)
- Materials Science (15)
- Microscopy (3)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (1)
- Neutron Science (9)
- Physics (6)
- Polymers (2)
- Quantum Science (4)
- Summit (1)
- Sustainable Energy (4)
Media Contacts
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Momentum Technologies Inc., a Dallas, Texas-based materials science company that is focused on extracting critical metals from electronic waste, has licensed an Oak Ridge National Laboratory process for recovering cobalt and other metals from spent
Scientists at Oak Ridge National Laboratory and Ohio State University discovered a new microbial pathway that produces ethylene, providing a potential avenue for biomanufacturing a common component of plastics, adhesives, coolants and other
Real-time measurements captured by researchers at ORNL provide missing insight into chemical separations to recover cobalt, a critical raw material used to make batteries and magnets for modern technologies.
Five researchers at the Department of Energy’s Oak Ridge National Laboratory have been named ORNL Corporate Fellows in recognition of significant career accomplishments and continued leadership in their scientific fields.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.